Wednesday, September 01 2010
The FDA has granted 510(k) clearance for the LipiScan near-infrared (NIR) and intravascular ultrasound (IVUS) coronary imaging system from InfraReDx.
Friday, August 27 2010
SonoSite has received FDA clearance for its tracking and guidance technology for peripherally inserted central catheter line procedures, the LumenVu Catheter Guidance System.
Thursday, August 19 2010
Cancer and benign disease equipment manufacturer BSD Medical has been granted FDA clearance to market its soft tissue ablation system, the MicroThermX Microwave Ablation System, in the U.S.
Monday, August 09 2010
The FDA has accepted Bayer Schering Pharma's new drug application (NDA) for its gadolinium-based contrast agent for MR imaging, gadobutrol injection (Gadovist 1.0).
Thursday, August 05 2010
Elekta has received the CE mark for its digital imaging system, iView, for use with Elekta Compact, its linear accelerator for radiation therapy.
Thursday, August 05 2010
Breast cancer device developer Orbital Therapy has received a U.S. patent for a self-shielded radiotherapy device, which does not require a traditional vault for operation.
Wednesday, August 04 2010
The FDA has cleared VeraLook, iCAD’s computer-aided detection product, used in the interpretation of virtual colonoscopy exams.
Wednesday, July 28 2010
Roche Diagnostics has received 510(k) clearance from the U.S. FDA for the CoaguChek XS Pro system, a point-of-care anticoagulation monitor with a built-in barcode reader that can capture operator and patient identification information.
Wednesday, July 28 2010
AirStrip Technologies has received FDA clearance to market the AirStrip remote patient monitoring (RPM) tool, including AirStrip RPM Critical Care and AirStrip RPM Cardiology.
Tuesday, July 27 2010
The U.S. Patent and Trademark Office has issued digital pathology company Aperio Technologies patent No. 7,738,688 entitled, “System and Method for Viewing Virtual Slides.”
Thursday, July 22 2010
ClearPractice has been authorized by the Centers for Medicare & Medicaid Services, allowing eligible customers to qualify for a 2 percent reimbursement when they use the company’s e-prescribing tool and a 2 percent reimbursement for Physician Quality Reporting Initiative reporting through the patient registry within ClearPractice’s EMR.
Tuesday, July 20 2010
The FDA has issued 510(k) clearance to Fujifilm Medical Systems for its FDR D-EVO, a flat-panel cassette detector.
Tuesday, July 20 2010
Siemens Healthcare now is offering a new multi-functional workstation for urology, the Uroskop Omnia, which has just received FDA clearance.
Thursday, July 15 2010
MedForce Technologies’ document management software, MedForce Scan, has received preliminary American Recovery and Reinvestment Act of 2009 (ARRA) certification as an EHR Module following inspection by the Certification Commission for Health Information Technology (CCHIT).
Tuesday, July 13 2010
Neoprobe has completed the preliminary review of information to be contained in the chemistry, manufacturing and control (CMC) module of its proposed new drug application for Lymphoseek with the FDA.
Friday, July 09 2010
Magnisense has received the patent from U.S. Patent and Trademark Office titled "Method for Analyzing a Mixture of Biological and/or Chemical Components using Magnetic Particles and Device for the Implementation of said Method" -- a patent which had already been granted in Europe in 2009.
Tuesday, July 06 2010
Medrad, a unit of Bayer HealthCare, has received FDA clearance to market its Intego PET infusion system for 18F-Sodium Fluoride (NaF) administration in PET imaging to find and assess bone metastases.
Wednesday, June 23 2010
Carestream Molecular Imaging, a division of Carestream Health, has been granted Patent No. 7,734,325 by the U.S. Patent and Trademark Office for the technology titled “apparatus and method for multi-modal imaging,” related to its in vivo multispectral FX small animal imaging system.
Wednesday, June 23 2010
Cell Point has submitted to the FDA an investigational new drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with coronary artery disease (CAD).
Monday, June 21 2010
The FDA has granted approval for Riverain Medical’s newest version of the OnGuard chest x-ray computer-aided detection (CAD) technology.
|